Latest research
Latest corporate research
Latest tax advantaged reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax advantaged research
Product reports for investors and advisors
Latest published research
Addressing the “risk off” investment challenge
5th Jun 2025
Pharma thoughts | Good move by GSK?
30th May 2025
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Bespoke valuation services
Bespoke valuation services
Services for clients with specific needs
Services for funds
Tax advantaged research
Product reports for investors and advisors.
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
Update on The EIS Navigator podcast
Stay up-to-date with the latest research
Sign up to our newsletter
Latest Corporate research
Our research can be accessed for free under MIFID.
Find out more >
All Corporate research
- Update
- Monthly Report
- Sector Report
- Initiation
All sectors
Agriculture
Building & Construction
Consumer
Financials
Industrial
Infrastructure
Investment Companies
Life Sciences
Media
Mining
Oil & Gas
Property
Renewables
Services
Technology
Transportation
Utilities
list companies
The Monthly: October 2024
01 Oct 2024
The International Stock Exchange
Financials
Strong bounce back continues
By
Jason Streets
30 Sep 2024
Stay up-to-date with the latest research
Sign up to our newsletter
Apax Global Alpha
Investment Companies
1H’24: deal activity coming back strongly
By
Mark Thomas
26 Sep 2024
Chesnara Plc
Financials
Steady as she goes!
By
Dr Brian Moretta
26 Sep 2024
Tissue Regenix
Life Sciences
Maiden pre-tax profit
By
Dr Martin Hall
23 Sep 2024
Volta Finance
Investment Companies
FY’24: another year of outperformance
By
Mark Thomas
11 Sep 2024
Shield Therapeutics Plc
Life Sciences
Focusing on successful execution
By
Dr Martin Hall
11 Sep 2024
The TikTok generation are becoming “renegade” investors
05 Sep 2024
The Monthly: September 2024
02 Sep 2024
H&T Group
Financials
1H’24 results: Four-one at half time, but the one wins
By
Mark Thomas
20 Aug 2024
Surface Transforms
Industrial
Pre-close trading, AGM and prospects
By
Mike Foster
13 Aug 2024
Prev
1
...
3
4
5
6
7
...
80
Next
